NASDAQ:EGRX

Eagle Pharmaceuticals Stock Insider Trading

etoro logo Buy EGRX
*Your capital is at risk
$0.160
+0.103 (+182.69%)
At Close: Jul 21, 2026

Eagle Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 1.27M and sold 271.88K EGRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 1.27M shares
Sell 271.88K shares
46% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jan 05, 2023
Sell
Common Stock
F-InKind
Tarriff Scott
CEO
CEO / President 3 827
Value: $112.0K
Jan 05, 2023
Sell
Common Stock
F-InKind
Tarriff Scott
CEO
CEO / President 3 827
Value: $112.0K
Jan 05, 2023
Sell
Common Stock
F-InKind
Cahill Brian Joseph
Chief Financial Officer
C-Suite Officer 734
Value: $21.5K
Dec 19, 2022
Sell
Common Stock
F-InKind
Cahill Brian Joseph
Chief Financial Officer
C-Suite Officer 461
Value: $13.8K
Dec 19, 2022
Sell
Common Stock
F-InKind
Cahill Brian Joseph
Chief Financial Officer
C-Suite Officer 461
Value: $13.8K
Sep 06, 2022
Sell
Common Stock
S-Sale
Edlin Richard A.
Director 6 800
Value: $210.7K
Sep 06, 2022
Sell
Common Stock
S-Sale
Edlin Richard A.
Director 6 800
Value: $210.7K
Feb 28, 2022
Buy
Stock Option (right to buy)
A-Award
Borio Luciana
Director
Director 11 200
Value: $530.8K
Feb 28, 2022
Buy
Common Stock
A-Award
Moran Michael Shawn
EVP, Chief Commercial Officer
Officer 10 400
Value: $0
Feb 28, 2022
Buy
Common Stock
A-Award
Cahill Brian Joseph
Chief Financial Officer
C-Suite Officer 8 000
Value: $0
Feb 28, 2022
Buy
Stock Option (right to buy)
A-Award
Edlin Richard A.
Director
Director 11 200
Value: $530.8K
Feb 28, 2022
Buy
Stock Option (right to buy)
A-Award
Simpson Jennifer K.
Director
Director 11 200
Value: $530.8K
Feb 28, 2022
Buy
Stock Option (right to buy)
A-Award
Ratoff Steven B
Director
Director 11 200
Value: $530.8K
Feb 28, 2022
Buy
Common Stock
A-Award
Tarriff Scott
CEO
CEO / President 34 800
Value: $0
Feb 28, 2022
Buy
Stock Option (right to buy)
A-Award
Graves Michael
Director
Director 11 200
Value: $530.8K
Feb 28, 2022
Buy
Stock Option (right to buy)
A-Award
Glenning Robert
Director
Director 11 200
Value: $530.8K
Feb 28, 2022
Buy
Stock Option (right to buy)
A-Award
Glenning Robert
Director
Director 11 200
Value: $530.8K
Feb 28, 2022
Buy
Stock Option (right to buy)
A-Award
Graves Michael
Director
Director 11 200
Value: $530.8K
Feb 28, 2022
Buy
Common Stock
A-Award
Tarriff Scott
CEO
CEO / President 34 800
Value: $0
Feb 28, 2022
Buy
Stock Option (right to buy)
A-Award
Simpson Jennifer K.
Director
Director 11 200
Value: $530.8K
Feb 28, 2022
Buy
Stock Option (right to buy)
A-Award
Ratoff Steven B
Director
Director 11 200
Value: $530.8K
Feb 28, 2022
Buy
Stock Option (right to buy)
A-Award
Edlin Richard A.
Director
Director 11 200
Value: $530.8K
Feb 28, 2022
Buy
Common Stock
A-Award
Cahill Brian Joseph
Chief Financial Officer
C-Suite Officer 8 000
Value: $0
Feb 28, 2022
Buy
Common Stock
A-Award
Moran Michael Shawn
EVP, Chief Commercial Officer
Officer 10 400
Value: $0
Feb 28, 2022
Buy
Stock Option (right to buy)
A-Award
Borio Luciana
Director
Director 11 200
Value: $530.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT EAGLE PHARMACEUTICALS
Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium ...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.35% Jul 13
JLL
$299.78
8.73% Jun 24
NMRK
$15.02
3.26% Jun 24
NESR
$25.07
8.62% Jun 23
CAG
$13.43
9.20% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE